Venetoclax‐Based Therapy for Early Relapse in Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report and Minireview

ABSTRACT Background Refractory/relapsed acute myeloid leukemia (R/R‐AML) typically exhibits resistance to conventional chemotherapy, resulting in a poor overall therapeutic outcome. Salvage allogeneic hematopoietic stem cell transplantation (allo‐HSCT) is the primary treatment option in such patient...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Yufeng Du, Mohammad Arian Hassani, Chunhong Li, Zhijia Zhao, Yikun Liu, Chengtao Zhang, Jinsong Yan
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Wiley 2026-01-01
Schriftenreihe:	Cancer Reports
Schlagworte:	acute myeloid leukemia allogeneic hematopoietic stem cell transplantation azacitidine donor lymphocyte infusion refractory/relapsed venetoclax
Online-Zugang:	https://doi.org/10.1002/cnr2.70450
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!